Madrigal Pharmaceuticals Inc
-
Health News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
[ad_1] In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen. Rafael Henrique | SOPA Images…
Read More » -
Health News
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
[ad_1] Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin…
Read More »